Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge CB2 3EB, United Kingdom.
J Neurosci. 2013 Apr 3;33(14):5903-14. doi: 10.1523/JNEUROSCI.4854-12.2013.
How is the cognitive performance of the human brain related to its topological and spatial organization as a complex network embedded in anatomical space? To address this question, we used nicotine replacement and duration of attentionally demanding task performance (time-on-task), as experimental factors expected, respectively, to enhance and impair cognitive function. We measured resting-state fMRI data, performance and brain activation on a go/no-go task demanding sustained attention, and subjective fatigue in n = 18 healthy, briefly abstinent, cigarette smokers scanned repeatedly in a placebo-controlled, crossover design. We tested the main effects of drug (placebo vs Nicorette gum) and time-on-task on behavioral performance and brain functional network metrics measured in binary graphs of 477 regional nodes (efficiency, measure of integrative topology; clustering, a measure of segregated topology; and the Euclidean physical distance between connected nodes, a proxy marker of wiring cost). Nicotine enhanced attentional task performance behaviorally and increased efficiency, decreased clustering, and increased connection distance of brain networks. Greater behavioral benefits of nicotine were correlated with stronger drug effects on integrative and distributed network configuration and with greater frequency of cigarette smoking. Greater time-on-task had opposite effects: it impaired attentional accuracy, decreased efficiency, increased clustering, and decreased connection distance of networks. These results are consistent with hypothetical predictions that superior cognitive performance should be supported by more efficient, integrated (high capacity) brain network topology at greater connection distance (high cost). They also demonstrate that brain network analysis can provide novel and theoretically principled pharmacodynamic biomarkers of pro-cognitive drug effects in humans.
人类大脑的认知表现与其作为嵌入解剖空间的复杂网络的拓扑和空间组织有何关系?为了解决这个问题,我们使用尼古丁替代物和注意力要求高的任务持续时间(任务时间)作为实验因素,分别预期增强和损害认知功能。我们在一项需要持续注意力的 Go/No-Go 任务中测量了静息状态 fMRI 数据、表现和大脑激活,以及 n = 18 名健康、短暂戒烟、香烟吸烟者的主观疲劳,这些吸烟者在安慰剂对照、交叉设计中重复扫描。我们测试了药物(安慰剂与 Nicorette 口香糖)和任务时间对行为表现和在 477 个区域节点的二进制图中测量的脑功能网络指标的主要影响(效率,整合拓扑的度量;聚类,分离拓扑的度量;以及连接节点之间的欧几里得物理距离,布线成本的代理标记)。尼古丁在行为上增强了注意力任务的表现,提高了效率,降低了聚类,增加了大脑网络的连接距离。尼古丁的更大行为益处与药物对整合和分布式网络配置的更强作用以及吸烟频率的增加相关。更长的任务时间具有相反的效果:它会损害注意力准确性,降低效率,增加聚类,减少网络的连接距离。这些结果与假设一致,即更优越的认知表现应该得到更有效的支持,整合(高容量)大脑网络拓扑在更大的连接距离(高成本)下。它们还表明,脑网络分析可以为人类认知增强药物效应提供新的和理论上有原则的药效动力学生物标志物。